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Introduction 
 Artificial neural network (ANN) is a powerful nonlinear 
statistical paradigm for recognition of complex 
patterns with the ability to maintain accuracy even when some input data are missing. ANN is able 
to perform certain specific task that mimics the acts 
of human brain, with its neurons and synaptic connections 
[1—3]. In ANN, the output performance for 
particular input variables of the network is optimised 
by adjusting the weights during the training 
process. The back propagation-training algorithm is 
commonly used for ANN in medical databases and 
has been shown by many researchers to be a powerful 
tool for prediction, prognosis and diagnosis in 
medical applications [4—9]. The outcome of these 
research findings showed promising result and enable 
a more effective resource planning and patient 
management. However, the use of ANN as a prognostic 
tool in dengue fever (DF) and dengue haemorrhagic 
fever (DHF) diseases has not been reported 
in the literature. Hence, this paper will be the first 
attempt to apply ANN for prognostic purpose in DF 
and DHF. 
 DF is an acute febrile viral disease frequently 
presenting with sign and symptoms that include 
headache, myalgia, macular rash, loss of appetite, 
nausea, vomiting, abdominal pain, metallic taste of 
food, change in psychological state and moderate 
thrombocytopenia [10]. A significant number of 
DF patients will progress to dengue haemorrhagic 
fever (DHF). DHF is the complication of DF around 
the day of defervescence of fever. The mechanism 
of progression from DF to DHF is related to 
immune mediated injury to the endothelium of 
the capillary, leading to plasma leakage from the 
capillary system, resulting in haemoconcentration, 
ascites, and pleural effusion and shock. It has been 
well documented that these serious complications 
usually set in following the day of defervescence of 
fever [11—13]. Since the early clinical features of 
DHF are indistinguishable from DF [11,14—16], the 
major pathophysiological changes that determine 
the severity of disease in DHF and also differentiates 
it from DF is plasma leakage resulting in 
increasing haematocrit (20% absolute rise from 
the baseline) leading to haemoconcentration, and 
a serous effusion that may lead to hypotension 
[11,17,18]. Defervescence is defined as the day 
when a patient has no fever or the disappearance 
of a fever. Fever is defined as the state when 
the body temperature rises above 37.5 ◦C [19]. 
Furthermore, patients who progress to shock will 
suddenly deteriorate at the time of, or shortly 
following defervescence of fever. These patients 
are in danger of dying if appropriate treatment is 
not promptly administered. Septic shock syndrome 
with vasodilatation, abnormal haemostasis and 
plasma leakage are the three pathophysiologic 
hallmarks of DHF [11,14,15]. These characteristic 
features typically occur at the onset of defervescence 
of fever [11,14—16]. Thus, the final diagnosis 
of severity of any dengue infection is unfortunately 
a retrospective one, after the progression of the 
illness has come to its end. Although most patients 
recover without sequel but a small minority may die 
from dengue shock syndrome (DSS). As a result, the 
mainstay of treatment remains as early diagnosis, 
close monitoring and aggressive fluid replacement 
therapy when indicated. The majority of patients 
were probably admitted for close monitoring and 
aggressive treatment merely due to anticipation of 
DSS. Decision making on when to admit or discharge 
patient has been a great challenge for the managing 
physician because there are very few clinical 
studies that address these issues. If the potentially 
ill patients can be identified confidently in time, a 
lot of unnecessary admission can be avoided. This 
will definitely has major impact on health care cost 
saving in view of the huge incident of dengue fever 
in this region. Thus, it is very crucial to know the 
day of defervescence of fever. If this information is 
made known beforehand to the clinician, early and 
proper clinical management and treatment can be 
planned to avoid mortality. This paper describes 
the development of a prognostic system to predict 
the day of defervescence of fever in DF and DHF 
patients using Matlab’s neural network toolbox 
[20]. The data have been collected from a total 
of 252 hospitalised patients (4 DF and 248 DHF 
patients). 
 
Dengue fever (DF) and dengue 
hemorrhagic fever (DHF) 
 The dengue viruses are members of the Flavivirus 
family. They consist of four serotypes and are 
transmitted by Aedes aegypti and Aedes albopictus 
mosquitoes. It is the commonest arthropod-borne 
viral infection in man [21]. It is estimated that as 
many as 100 million dengue virus infections occur 
annually in the tropics, with over 10,000 deaths 
from DHF [22]. Besides a rapid global increase in incidence, 
there has been an increase in severe cases 
as well [12,23]. Malaysia had its largest outbreak 
in the year 1996; a total of 14,255 dengue cases 
were notified of which 533 were DHF with 32 deaths 
[24,25]. 
 Adult DF is typically a flu-like illness characterized 
by fever, headache, eye pain, myalgia, arthralgia, 
and rash, which last from 5 to 7 days. DHF 
has been graded according to the WHO specifications 
into four grades of severity, where grades III 
and IV are considered to be DSS. Grade I is defined 
as patients having a fever accompanied by nonspecific 
constitutional symptoms, the only haemorrhagic manifestation is a positive tourniquet test 
that result in petechial rash. Grade II is defined as 
patients having a spontaneous bleeding from any 
site of their body skin. Grade III (DSS) is where a patient 
has circulatory failure manifested by rapid and 
weak pulse, narrowing of pulse pressure (20mmHg 
or less) or hypotension, with the presence of cold 
clammy skin and restlessness. Grade IV (DSS) is defined 
as patients having profound shock with undetectable 
blood and pulse [11]. 
 The characteristics of DF and DHF described 
above provide features that are amenable for a nonlinear 
modeling especially using ANN. 
 
Artificial neural networks (ANNs) 
 Artificial neural networks (ANNs) have been widely 
applied to non-linear modeling problems, and they 
are highly suitable for modeling complex databases 
of medical information. The work carried out in this 
paper employed a multilayer feed-forward neural 
network (MFNN) trained via steepest descent back 
propagation algorithm [3,4,8,26—39]. At each iteration 
of this algorithm the sum-squared-error (SSE) 
of the network prediction is used as the cost function. 
Many literatures refer to the SSE as the error 
goal [27—30,32—34]. The hyperbolic tangent function 
was used for the ANN activation [27]. Since the 
training algorithm may produce over fittings, pruning 
technique was employed. 
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